|[February 05, 2014]
Research and Markets: Hemoglobinopathies - Pipeline Review, H2 2013 Research Report
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/5z974p/hemoglobinopathies)
has announced the addition of the "Hemoglobinopathies
- Pipeline Review, H2 2013" report to their offering.
'Hemoglobinopathies - Pipeline Review, H2 2013', provides an overview of
the indication's therapeutic pipeline. This report provides information
on the therapeutic development for Hemoglobinopathies, complete with
latest updates, and special features on late-stage and discontinued
projects. It also reviews key players involved in the therapeutic
development for Hemoglobinopathies.
- A snapshot of the global therapeutic scenario for Hemoglobinopathies.
- A review of the Hemoglobinopathies products under development by
companies and universities/research institutes based on information
derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging
from discovery till egistration stages.
- A feature on pipeline projects on the basis of monotherapy and
- Coverage of the Hemoglobinopathies pipeline on the basis of route of
administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Some Key Topics Covered:
Pipeline Products for Hemoglobinopathies - Overview
Pipeline Products for Hemoglobinopathies - Comparative Analysis
Hemoglobinopathies - Therapeutics under Development by Companies
Hemoglobinopathies - Pipeline Products Glance
Clinical Stage Products
Early Stage Products
Hemoglobinopathies - Products under Development by Companies
Hemoglobinopathies - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target (News - Alert)
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Assessment by Therapeutic Class
NiCord - Drug Profile
ZFP Transcription Factors For Hemoglobinopathies - Drug Profile
ALN-TMP - Drug Profile
Drug Targeting PRMT5 - Drug Profile
Drug Targeting Protein Arginine Methyltransferase 5 - Drug Profile
Hemoglobinopathies - Recent Pipeline Updates
Hemoglobinopathies - Product Development Milestones
Sangamo BioSciences, Inc.
Gamida Cell Ltd.
Alnylam Pharmaceuticals, Inc.
Cancer Therapeutics CRC Pty Ltd
For more information visit http://www.researchandmarkets.com/research/5z974p/hemoglobinopathies
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To TMCnet.com's Homepage ]